Skip to main content
. 2022 May 31;20(2):320–329. doi: 10.9758/cpn.2022.20.2.320

Table 4.

Self-controlled case series analyses of subgroup

Risk period MPH start within 3 years after ADHD diagnosis MPH start within 1 years after ADHD diagnosis


No. of events IRR (95% CI) pvalue No. of events IRR (95% CI) pvalue
Total
Unexposed 1,701 1 1,474 1
Pre exposed: 90 d 104 11.7 (9.5−14.42) < 0.001 87 12.41 (9.87−15.6) < 0.001
Exposed 3,492 19.37 (17.77−21.11) < 0.001 2,781 20.93 (19.02−23.03) < 0.001
After exposed: 30 d 41 2.78 (2.04−3.81) < 0.001 36 3.09 (2.21−4.32) < 0.001
After exposed: 31−60 d 17 1.21 (0.75−1.95) 0.439 15 1.35 (0.81−2.25) 0.253
After exposed: 61−90 d 26 1.93 (1.3−2.84) < 0.001 20 1.87 (1.2−2.92) 0.006
Age 1.58 (1.56−1.61) < 0.001 1.62 (1.6−1.65) < 0.001
Age 6 to 9 years
Unexposed 447 1 351 1
Pre exposed: 90 d 32 11.91 (8.19−17.31) < 0.001 22 12.07 (7.7−18.91) < 0.001
Exposed 1,777 17.21 (14.99−19.75) < 0.001 1,328 18.5 (15.78−21.68) < 0.001
After exposed: 30 d 11 1.72 (0.94−3.14) 0.079 9 1.81 (0.93−3.53) 0.082
After exposed: 31−60 d 4 0.69 (0.26−1.86) 0.464 3 0.67 (0.21−2.1) 0.493
After exposed: 61−90 d 9 1.7 (0.88−3.3) 0.117 8 1.96 (0.97−3.98) 0.061
Age 1.53 (1.5−1.56) < 0.001 1.58 (1.54−1.62) < 0.001

CI, confidence interval; MPH, methylphenidate; ADHD, Attention Deficit Hyperactivity Disorder.